SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

10827	Companies
234901	Keywords
163761	Articles
125734	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/09/2025 at 07:00, 1 year 2 months ago

Press Release: Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season
Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season, ensuring broad availability and high efficacy for infants

Healthcare Sanofi Vaccine RSV Beyfortus
BRIEF

published on 06/06/2025 at 20:27, 1 year 2 months ago

Sanofi Discloses Repurchase of Own Shares in Early June 2025

Share Repurchase XPAR Market Stock Transaction 2025 Sanofi
BRIEF

published on 06/06/2025 at 20:27, 1 year 2 months ago

Sanofi annonce un rachat d'actions propres début juin 2025

Rachat D'actions Marché XPAR 2025 Sanofi Transaction Sur Actions
PRESS RELEASE

published on 06/06/2025 at 20:22, 1 year 2 months ago

Sanofi: Disclosure of trading in own shares
Sanofi discloses its trading in own shares from 02 June 2025 to 06 June 2025, repurchasing a total of 105,316 shares at an average price of 86.91 EUR per share on XPAR market

Trading Own Shares XPAR Repurchases Sanofi
PRESS RELEASE

published on 06/06/2025 at 20:22, 1 year 2 months ago

Sanofi : Déclaration des transactions sur actions propres
Sanofi déclare les transactions sur actions propres du 02 Juin 2025 au 06 Juin 2025 conformément à la réglementation. Présentation agrégée par jour et par marché

Actions Propres Transactions Réglementation Sanofi Présentation Agrégée
BRIEF

published on 06/02/2025 at 07:05, 1 year 2 months ago

Sanofi to Acquire Blueprint Medicines for $9.5 Billion

Rare Diseases Sanofi Acquisition Blueprint Medicines Immunology Pipeline Systemic Mastocytosis
BRIEF

published on 06/02/2025 at 07:05, 1 year 2 months ago

Sanofi va acquérir Blueprint Medicines pour 9,5 milliards de dollars

Maladies Rares Acquisition De Sanofi Médicaments Blueprint Pipeline D'immunologie Mastocytose Systémique
PRESS RELEASE

published on 06/02/2025 at 07:00, 1 year 2 months ago

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology
Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease. Acquisition includes Ayvakit/Ayvakyt for systemic mastocytosis and a promising pipeline in immunology

Acquisition Sanofi Rare Diseases Blueprint Medicines Immunological Disease
BRIEF

published on 05/30/2025 at 07:05, 1 year 2 months ago

Itepekimab Reaches Primary Endpoint in COPD Phase 3 Study

Sanofi COPD Regeneron Itepekimab AERIFY-1
BRIEF

published on 05/30/2025 at 07:05, 1 year 2 months ago

L'itepekimab atteint son critère d'évaluation principal dans l'étude de phase 3 sur la BPCO

Sanofi BPCO Regeneron Itepekimab AERIFY-1

Accesswire

Published on 08/13/2026 at 00:30, 32 minutes ago

Aton Closes CAD$4 Million Private Placement
Published on 08/12/2026 at 23:30, 1 hour 32 minutes ago

CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:30, 1 hour 32 minutes ago

Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle
Published on 08/12/2026 at 23:20, 1 hour 42 minutes ago

RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement
Published on 08/12/2026 at 23:05, 1 hour 57 minutes ago

Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend

View all ACCESSWIRE

EQS Group

Published on 08/12/2026 at 21:05, 3 hours 57 minutes ago

Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 5 hours 5 minutes ago

EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 5 hours 25 minutes ago

EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/12/2026 at 18:50, 6 hours 12 minutes ago

Holding(s) in Company
Published on 08/12/2026 at 18:29, 6 hours 33 minutes ago

Designated Persons Notifications

Les Echos

Published on 08/11/2026 at 17:45, 1 day 7 hours ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 7 hours ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 7 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 7 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 2 days 7 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE